GT-729

N/A

Report date: 2026/04/17 10:35:57

Base Information

Drug NameGT-729
Drug Alias NameGT-729
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator Companiesshenzhen Grit Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active Companiesshenzhen Grit Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A